1. Ministry of Health and Family Welfare, Government of India. COVID-19 vaccines operational guidelines. Updated December 28, 2020. [Internet]. [cited 2021 Jul 14]. Available from: https://main.mohfw.gov.in/sites/default/files/COVID19VaccineOG111Chapter16.pdf
2. World Health Organization. 2021. Interim recommendations for use of the ChAdOx1-S [recombinant] vaccine against COVID-19 (AstraZeneca COVID-19 vaccine AZD1222, SII Covishield, SK Bioscience). Available from: https://apps.who.int/iris/rest/bitstreams/1343289/retrieve. Last accessed 16 July 2021.
3. Ministry of Health and Family Welfare, Government of India. CoWIN Dashboard [Internet]. [cited 2021 July 16]. Available from: https://dashboard.cowin.gov.in/
4. Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials;Voysey;Lancet,2021
5. Vaccine breakthrough infections with SARS-CoV-2 variants;Hacisuleyman;N Engl J Med,2021